Skip to main content
. Author manuscript; available in PMC: 2009 Nov 15.
Published in final edited form as: Cancer Res. 2008 Nov 15;68(22):9512–9518. doi: 10.1158/0008-5472.CAN-08-0553

Figure 1.

Figure 1

Effect of fenretinide (top panel, A; FEN: fenretinide+placebo or fenretinide+tamoxifen) and tamoxifen (top panel B; TAM: tamoxifen+placebo and tamoxifen+fenretinide) and homeostasis model assessment (HOMA) index. The histograms indicate the percentage of subjects improving their HOMA index from baseline, shifting from HOMA ≥ 2.8 to HOMA < 2.8. Two years treatment followed by one year follow-up.